< Terug naar vorige pagina
Onderzoeker
Siegfried Segaert
- Disciplines:Dermatologie
Affiliaties
- Laboratorium Dermato-immunologie (Afdeling)
Lid
Vanaf1 jan 2012 → 31 dec 2017 - Laboratorium Dermatologie (Afdeling)
Lid
Vanaf1 okt 2001 → 31 dec 2011 - Klinische en Experimentele Endocrinologie (Afdeling)
Lid
Vanaf1 okt 1999 → 30 sep 2002
Publicaties
1 - 10 van 44
- Clinical Signs, Pathophysiology and Management of Cutaneous Side Effects of Anti-Tumor Necrosis Factor Agents(2017)
Auteurs: Siegfried Segaert
Pagina's: 771 - 787 - Optimizing Anti-Inflammatory and Immunomodulatory Effects of Corticosteroid and Vitamin D Analogue Fixed-Dose Combination Therapy(2017)
Auteurs: Siegfried Segaert
Pagina's: 265 - 279 - Reformulations of well-known active ingredients in the topical treatment of psoriasis vulgaris can improve clinical outcomes for patients(2017)
Auteurs: Siegfried Segaert
Pagina's: 1271 - 1284 - Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors(2017)
Auteurs: Siegfried Segaert, Hans Prenen
Pagina's: 102 - 113 - The association between etanercept serum concentration and psoriasis severity is highly age-dependent(2017)
Auteurs: Iris Detrez, Kristel Van Steen, Ann Gils, Siegfried Segaert
Pagina's: 1179 - 1189 - The paradoxical development of cutaneous squamous cell carcinoma and keratoacanthoma in patients with malignant melanoma treated with a BRAF-inhibitor(2017)
Auteurs: Siegfried Segaert
Pagina's: 487 - 492 - Current practice of therapeutic drug monitoring of biopharmaceuticals in psoriasis patients(2017)
Auteurs: Caroline Hermans, Siegfried Segaert, Ann Gils
Pagina's: 356 - 359 - An observational study of the real-life management of psoriasis patients treated with etanercept according to the new reimbursement criteria (in Belgium)(2016)
Auteurs: Siegfried Segaert
Pagina's: 103 - 109 - Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective(2016)
Auteurs: Siegfried Segaert
Pagina's: 128 - 133 - Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study(2016)
Auteurs: Isabelle Cleynen, Thomas Billiet, Niels Vande Casteele, Christine Breynaert, Vera Ballet, Marc Ferrante, Gert Van Assche, Paul Rutgeerts, Joost van den Oord, Ann Gils, et al.
Pagina's: 10 - 22